IMAC Holdings, Inc. (BACK)
USD 0.04
(45.21%)
USD 0.04
(45.21%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.89 Million USD | -70.5% |
| 2022 | 6.43 Million USD | -30.68% |
| 2021 | 9.27 Million USD | -22.26% |
| 2020 | 11.93 Million USD | -4.39% |
| 2019 | 12.48 Million USD | -16.83% |
| 2018 | 15 Million USD | 1254.84% |
| 2017 | 1.1 Million USD | 100.99% |
| 2016 | 551.09 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.15 Million USD | 13.35% |
| 2023 Q3 | 3.23 Million USD | -35.33% |
| 2023 Q4 | 1.89 Million USD | -41.39% |
| 2023 FY | 1.89 Million USD | -70.5% |
| 2023 Q1 | 4.84 Million USD | -24.64% |
| 2023 Q2 | 5 Million USD | 3.26% |
| 2022 Q2 | 7.97 Million USD | -13.6% |
| 2022 FY | 6.43 Million USD | -30.68% |
| 2022 Q3 | 6.97 Million USD | -12.49% |
| 2022 Q1 | 9.22 Million USD | -0.52% |
| 2022 Q4 | 6.43 Million USD | -7.84% |
| 2021 Q3 | 9.63 Million USD | -5.07% |
| 2021 FY | 9.27 Million USD | -22.26% |
| 2021 Q1 | 10.79 Million USD | -9.53% |
| 2021 Q4 | 9.27 Million USD | -3.77% |
| 2021 Q2 | 10.15 Million USD | -5.94% |
| 2020 Q4 | 11.93 Million USD | -7.37% |
| 2020 Q2 | 13.93 Million USD | 0.84% |
| 2020 Q1 | 13.82 Million USD | 10.74% |
| 2020 FY | 11.93 Million USD | -4.39% |
| 2020 Q3 | 12.88 Million USD | -7.57% |
| 2019 Q3 | 13.25 Million USD | 10.46% |
| 2019 Q4 | 12.48 Million USD | -5.84% |
| 2019 Q2 | 12 Million USD | 10.06% |
| 2019 Q1 | 10.9 Million USD | -27.34% |
| 2019 FY | 12.48 Million USD | -16.83% |
| 2018 Q2 | 12.7 Million USD | 265.12% |
| 2018 FY | 15 Million USD | 1254.84% |
| 2018 Q4 | 15 Million USD | 3.52% |
| 2018 Q3 | 14.49 Million USD | 14.07% |
| 2018 Q1 | 3.48 Million USD | 214.26% |
| 2017 Q4 | 1.1 Million USD | 0.0% |
| 2017 FY | 1.1 Million USD | 100.99% |
| 2016 FY | 551.09 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 99.923% |
| Addus HomeCare Corporation | 317.73 Million USD | 99.403% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | 98.536% |
| Amedisys, Inc. | 940.38 Million USD | 99.798% |
| Astrana Health, Inc. | 522.59 Million USD | 99.637% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 99.893% |
| biote Corp. | 191.84 Million USD | 99.011% |
| Cryo-Cell International, Inc. | 72.25 Million USD | 97.375% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | 99.079% |
| COMPASS Pathways plc | 50.24 Million USD | 96.225% |
| DocGo Inc. | 185.28 Million USD | 98.976% |
| The Ensign Group, Inc. | 2.68 Billion USD | 99.929% |
| Healthcare Services Group, Inc. | 346.56 Million USD | 99.453% |
| InnovAge Holding Corp. | 247.85 Million USD | 99.235% |
| The Joint Corp. | 62.37 Million USD | 96.959% |
| LifeStance Health Group, Inc. | 804.27 Million USD | 99.764% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | 50.231% |
| ModivCare Inc. | 1.61 Billion USD | 99.882% |
| NewGenIvf Group Limited | 1.24 Million USD | -52.788% |
| Option Care Health, Inc. | 1.9 Billion USD | 99.901% |
| P3 Health Partners Inc. | 427.3 Million USD | 99.556% |
| P3 Health Partners Inc. | 427.3 Million USD | 99.556% |
| The Pennant Group, Inc. | 394.17 Million USD | 99.519% |
| Surgery Partners, Inc. | 3.65 Billion USD | 99.948% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -108.419% |
| Talkspace, Inc. | 23.57 Million USD | 91.954% |
| Talkspace, Inc. | 23.57 Million USD | 91.954% |
| The Oncology Institute, Inc. | 162.39 Million USD | 98.832% |
| The Oncology Institute, Inc. | 162.39 Million USD | 98.832% |